Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · see citing works

Angiogenesis in cancer, vascular, rheumatoid and other disease

Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627 · see citing works

[6] Use of T7 RNA polymerase to direct expression of cloned genes

Studier, F. W., Rosenberg, A. H., Dunn, J. J., & Dubendorff, J. W. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)85008-c · Cited by 6,562 · see citing works

What Is the Evidence That Tumors Are Angiogenesis Dependent?

Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509 · see citing works

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605 · see citing works

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344 · see citing works

Transplacental Carcinogenesis by Stilbestrol

Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640 · see citing works

Clinical Applications of Research on Angiogenesis

Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,242 · see citing works

Plasminogen: Purification from Human Plasma by Affinity Chromatography

Deutsch, D. G., & Mertz, E. T. (1970) · Science · doi:10.1126/science.170.3962.1095 · Cited by 2,145 · see citing works

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,870 · see citing works

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,437 · see citing works

Cell death and control of cell survival in the oligodendrocyte lineage

Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., & Raff, M. C. (1992) · Cell · doi:10.1016/0092-8674(92)90531-g · Cited by 1,345 · see citing works

Model Predicting Survival in Stage I Melanoma Based on Tumor Progression

Clark, W. H., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., Synnestvedt, M. B., & Halpern, A. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1893 · Cited by 1,247 · see citing works

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,219 · see citing works

Angiostatin induces and sustains dormancy of human primary tumors in mice

O’Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,170 · see citing works

The implications of angiogenesis for the biology and therapy of cancer metastasis

Fidler, I. J. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,099 · see citing works

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Good, D. J., Polverini, P. J., Rastinejad, F., Beau, M. M. L., Lemons, R. S., Frazier, W. A., & Bouck, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,051 · see citing works

Important Advances in Oncology: 1986

Merrill, J. M. (1986) · JAMA · doi:10.1001/jama.1986.03380040106043 · Cited by 909 · see citing works

Long-term culture of capillary endothelial cells.

Folkman, J., Haudenschild, C. C., & Zetter, B. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5217 · Cited by 766 · see citing works

Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro

Grant, D. S., Tashiro, K., Seguí‐Real, B., Yamada, Y., Martin, G. R., & Kleinman, H. K. (1989) · Cell · doi:10.1016/0092-8674(89)90945-8 · Cited by 740 · see citing works

Inhibition of Angiogenesis In Vivo by Interleukin 12

Voest, E. E., Kenyon, B. M., OʼReilly, M., Truitt, G. A., D’Amato, R. J., & Folkman, J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.8.581 · Cited by 722 · see citing works

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.

Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.155 · Cited by 704 · see citing works

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 698 · see citing works

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., & Dvorak, H. F. (1993) · PubMed · Cited by 635 · see citing works

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

Tolsma, S. S., Volpert, O. V., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.2.497 · Cited by 572 · see citing works

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

Kandel, J. J., Bossy‐Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., & Hanahan, D. (1991) · Cell · doi:10.1016/0092-8674(91)90033-u · Cited by 507 · see citing works

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene

Rastinejad, F., Polverini, P. J., & Bouck, N. (1989) · Cell · doi:10.1016/0092-8674(89)90238-9 · Cited by 460 · see citing works

Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats

Bursch, W., Paffe, S., Putz, B., Barthel, G., & Schulte‐Hermann, R. (1990) · Carcinogenesis · doi:10.1093/carcin/11.5.847 · Cited by 444 · see citing works

Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

Fisher, B., Gündüz, N., & Saffer, E. (1983) · PubMed · Cited by 421 · see citing works

Effect of surgical removal on the growth and kinetics of residual tumor.

Gündüz, N., Fisher, B., & Saffer, E. (1979) · PubMed · Cited by 412 · see citing works

A model of angiogenesis in the mouse cornea.

Kenyon, B. M., Voest, E. E., Chen, C. C., Flynn, E. A., Folkman, J., & D’Amato, R. J. (1996) · PubMed · Cited by 403 · see citing works

Kringle Domains of Human Angiostatin

Cao, Y., Ji, R. W., Davidson, D. J., Schaller, J., Marti, D. N., Söhndel, S., McCance, S. G., O’Reilly, M. S., Llinás, M., & Folkman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29461 · Cited by 368 · see citing works

Presence of a growth-stimulating factor in serum following primary tumor removal in mice.

Fisher, B., Gündüz, N., Coyle, J., Rudock, C., & Saffer, E. (1989) · PubMed · Cited by 361 · see citing works

Multifactorial analysis of p53 alteration in human cancer: A review

Soussi, T., Legros, Y., Lubin, R., Ory, K., & Schlichtholz, B. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570102 · Cited by 351 · see citing works

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.

Parangi, S., OʼReilly, M., Christofori, G., Holmgren, L., Grosfeld, J. A., Folkman, J., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2002 · Cited by 343 · see citing works

The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis

Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/endo.133.3.7689950 · Cited by 338 · see citing works

Tumor angiogenesis and tissue factor

Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0296-167 · Cited by 295 · see citing works

Interferon γ-Inducible Protein-10 (IP-10), a Member of the C-X-C Chemokine Family, Is an Inhibitor of Angiogenesis

Strieter, R. M., Kunkel, S. L., Arenberg, D. A., et al. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1626 · Cited by 289 · see citing works

Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor.

Hori, A., Sasada, R., Matsutani, E., et al. (1991) · PubMed · Cited by 263 · see citing works

Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro.

Gross, J. L., Moscatelli, D., & Rifkin, D. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2623 · Cited by 261 · see citing works

Quantitation of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane

Nguyen, M. T. N., Shing, Y., & Folkman, J. (1994) · Microvascular Research · doi:10.1006/mvre.1994.1003 · Cited by 245 · see citing works

Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents

Teicher, B. A., Holden, S. A., Ara, G., Sotomayor, E. A., Huang, Z. D., Chen, Y., & Brem, H. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570624 · Cited by 231 · see citing works

Localization of Individual Lysine‐Binding Regions in Human Plasminogen and Investigations on Their Complex‐Forming Properties

LERCH, P. G., Rickli, E. E., Lergier, W., et al. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb04617.x · Cited by 223 · see citing works

Plasminogen

Ponting, C. P., Marshall, J. M., & Cederholm-Williams, S. A. (1992) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199210000-00012 · Cited by 216 · see citing works

Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor GrowthPreprint

OʼReilly, M., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Cao, Y., Moses, M. A., Lane, W. S., Sage, E. H., & Folkman, J. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.052 · Cited by 216 · see citing works

Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.

Gately, S. T., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L. N., Cundiff, D. L., Schnaper, H. W., Madison, L. D., Volpert, O. V., Bouck, N., et al. (1996) · PubMed · Cited by 197 · see citing works

Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones.

Muragaki, Y., Timmons, S., Griffith, M., Oh, S. P., Fadel, B. M., Quertermous, T., & Olsen, B. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8763 · Cited by 194 · see citing works

Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins.

Oh, S. P., KAMAGATA, Y., Muragaki, Y., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4229 · Cited by 189 · see citing works

Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen.

Rehn, M., & Pihlajaniemi, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4234 · Cited by 180 · see citing works

Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2.

Sakamoto, N., Iwahana, M., Tanaka, N., et al. (1991) · PubMed · Cited by 159 · see citing works

Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus

Lane, W. S., Gałat, A., Harding, M. W., & Schreiber, S. L. (1991) · Journal of Protein Chemistry · doi:10.1007/bf01024778 · Cited by 159 · see citing works

Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.

Milas, L., Hunter, N. R., Mason, K. A., et al. (1974) · PubMed · Cited by 149 · see citing works

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

Gupta, S. K., Hassel, T., & Singh, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7799 · Cited by 141 · see citing works

The inhibition of tumor growth by tumor mass.

Prehn, R. T. (1991) · PubMed · Cited by 136 · see citing works

gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice.

Cao, Y., Chen, C., Weatherbee, J. A., Tsang, M., & Folkman, J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.2069 · Cited by 135 · see citing works

Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge

Gorelik, E. (1983) · Advances in cancer research · doi:10.1016/s0065-230x(08)61033-7 · Cited by 134 · see citing works

A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology.

Obeso, J. L., Weber, J. B., & Auerbach, R. (1990) · PubMed · Cited by 132 · see citing works

Identification of Three N-terminal Ends of Type XVIII Collagen Chains and Tissue-specific Differences in the Expression of the Corresponding Transcripts

Rehn, M., & Pihlajaniemi, T. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4705 · Cited by 128 · see citing works

Factors in the Production and Growth of tumor Metastases.

Tyzzer, E. E. (1913) · PubMed · Cited by 124 · see citing works

On Concomitant Immunity in Tumour-bearing Hamsters

Gershon, R. K., Carter, R. L., & KONDO, K. (1967) · Nature · doi:10.1038/213674a0 · Cited by 119 · see citing works

Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth.

Homandberg, G. A., Williams, J. E., Grant, D., et al. (1985) · PubMed · Cited by 116 · see citing works

An experimental study of postoperative tumor metastases.I. Growth of pulmonary metastases following total removal of primary leg tumor

Schatten, W. E. (1958) · Cancer · doi:10.1002/1097-0142(195805/06)11:3 · Cited by 111 · see citing works

Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis

Hamada, J., Cavanaugh, P. G., Lotan, O., & Nicolson, G. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.269 · Cited by 107 · see citing works

A strategy to discover circulating angiogenesis inhibitors generated by human tumors.

Chen, C., Parangi, S., Tolentino, M. J., & Folkman, J. (1995) · PubMed · Cited by 99 · see citing works

GROWTH OF A LOCAL TUMOR EXERTS A SPECIFIC INHIBITORY EFFECT ON PROGRESSION OF LUNG METASTASES

Gorelik, E., Segal, S., & Feldman, M. M. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210512 · Cited by 94 · see citing works

Two competing influences that may explain concomitant tumor resistance.

Prehn, R. T. (1993) · PubMed · Cited by 89 · see citing works

Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-Sepharose, and fibrin cleaved by plasmin

Bok, R., & Mangel, W. F. (1985) · Biochemistry · doi:10.1021/bi00334a031 · Cited by 83 · see citing works

Angiogenesis and its inhibitors.

Folkman, J. (1985) · PubMed · Cited by 80 · see citing works

An elastase-dependent pathway of plasminogen activation

Machovich, R., & Owen, W. G. (1989) · Biochemistry · doi:10.1021/bi00436a059 · Cited by 72 · see citing works

Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture

Nicosia, R. F., Tchao, R., & Leighton, J. (1986) · Clinical & Experimental Metastasis · doi:10.1007/bf00119076 · Cited by 71 · see citing works

“Concomitant immunity” in murine tumours of non-detectable immunogenicity

Ruggiero, R. A., Bustuoabad, O. D., Bonfil, R. D., Meiss, R. P., & Pasqualini, C. D. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.6 · Cited by 69 · see citing works

Alpha 1 (XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen

Rehen, M. (1994) · Medical Entomology and Zoology · Cited by 66 · see citing works

Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca2+‐binding EF‐hand sequence

Sage, E. H., Bassuk, J. A., Yost, J. C., Folkman, M. J., & Lane, T. F. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570113 · Cited by 65 · see citing works

Control of Lung Metastasis Progression in Mice: Role of Growth Kinetics of 3LL Lewis Lung Carcinoma and Host Immune Reactivity 2 , 3

5, E. G., Segal, S., & Feldman, M. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/65.6.1257 · Cited by 62 · see citing works

The inhibitory influence of a transplanted hamster lymphoma on metastasis.

Greene, H. S. N., & Harvey, E. K. (1960) · PubMed · Cited by 55 · see citing works

On the mechanism of tumor ‘concomitant immunity’

Gorelik, E., Segal, S., & Feldman, M. M. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910270618 · Cited by 50 · see citing works

The natural and induced resistance of mice to the growth of cancer

Bashford, E. F., Murray, J. A., & Cramer, W. (1907) · Proceedings of the Royal Society of London Series B Containing Papers of a Biological Character · doi:10.1098/rspb.1907.0014 · Cited by 50 · see citing works

Important Advances in Oncology 1986

Hellmän, S., DeVita, V. T., & Rosenberg, S. A. (1986) · Cited by 49 · see citing works

Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread.

Yuhas, J. M., & Pazmiño, N. H. (1974) · PubMed · Cited by 49 · see citing works

Resistance of tumor-bearing mice to a second tumor challenge.

Gorelik, E. (1983) · PubMed · Cited by 36 · see citing works

Murine epidermal growth factor (EGF) fragment (33-42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis.

NELSON, J., Allen, W. E., Scott, W. N., et al. (1995) · PubMed · Cited by 35 · see citing works

Role of concomitant resistance in the development of murine lung metastases

Bonfil, R. D., Ruggiero, R. A., Bustuoabad, O. D., et al. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410317 · Cited by 30 · see citing works

Potentiation of cigarette smoking and radiation evidence from a sputum cytology survey among uranium miners and controls

Band, P. R., Feldstein, M., Saccomanno, G., Watson, L., & King, G. (1980) · Cancer · doi:10.1002/1097-0142(19800315)45:6 · Cited by 25 · see citing works

Neutrophil proteases in plasminogen activation

Machovich, R., Himer, Á., & Owen, W. G. (1990) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199008000-00004 · Cited by 22 · see citing works

Concomitant immunity in hamsters bearing dmba‐induced tumor transplants

Lausch, R. N., & Rapp, F. (1969) · International Journal of Cancer · doi:10.1002/ijc.2910040213 · Cited by 21 · see citing works

Inhibition of Lewis lung tumor growth and metastasis by Ehrlich ascites tumor growing in the same host

Himmele, J. C., Rabenhorst, B., & Werner, D. (1986) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00400757 · Cited by 13 · see citing works

Angiogenesis in cancer and other diseases

Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · see citing works

New functions for the matrix metalloproteinases in cancer progression

Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108 · see citing works

Vascular-specific growth factors and blood vessel formation

Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · see citing works

Tumorigenesis and the angiogenic switch

Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559 · see citing works

Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid

Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · see citing works

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works

Angiogenesis as a therapeutic target

Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653 · see citing works

Concepts of extracellular matrix remodelling in tumour progression and metastasis

Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296 · see citing works

Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness

Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689 · see citing works

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683 · see citing works

Angiogenesis

Folkman, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131306 · Cited by 1,209 · see citing works

Fibroblasts in fibrosis: novel roles and mediators

Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082 · see citing works

Regulation of matrix biology by matrix metalloproteinases

Mott, J. D., & Werb, Z. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.010 · Cited by 1,104 · see citing works

Molecular mechanisms of blood vessel growth

Conway, E. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00281-9 · Cited by 1,030 · see citing works

Materials as stem cell regulators

Murphy, W. L., McDevitt, T. C., & Engler, A. J. (2014) · Nature Materials · doi:10.1038/nmat3937 · Cited by 947 · see citing works

Adipose tissue mass can be regulated through the vasculature

Rupnick, M. A., Panigrahy, D., Zhang, C.-Y., Dallabrida, S. M., Lowell, B. B., Langer, R., & Folkman, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162349799 · Cited by 845 · see citing works

Mechanisms of normal and tumor-derived angiogenesis

Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809 · see citing works

Angiogenesis: regulators and clinical applications

Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748 · see citing works

Angiogenesis modulates adipogenesis and obesity

Cao, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32239 · Cited by 736 · see citing works

Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice

Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688 · see citing works

Basement membrane proteoglycans: from cellar to ceiling

Iozzo, R. V. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1702 · Cited by 521 · see citing works

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Karsdal, M. A., Nielsen, S. H., Leeming, D. J., Langholm, L. L., Nielsen, M. J., Manon-Jensen, T., Siebuhr, A., Gudmann, N. S., Rønnow, S., Sand, J. M., et al. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.014 · Cited by 509 · see citing works

Exploiting the critical perioperative period to improve long-term cancer outcomes

Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487 · see citing works

A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype

Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj068 · Cited by 423 · see citing works

Anti-angiogenic therapy: current challenges and future perspectives

Lopes-Coelho, F., Martins, F., Pereira, S. A., & Serpa, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073765 · Cited by 416 · see citing works

Stress and cancer: mechanisms, significance and future directions

Eckerling, A., Ricon-Becker, I., Sorski, L., Sandbank, E., & Ben-Eliyahu, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00395-5 · Cited by 348 · see citing works

Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Liu, J., Wang, Y., Akamatsu, Y., Lee, C. C., Stetler, R. A., Lawton, M. T., & Yang, G.-Y. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.004 · Cited by 335 · see citing works

Priming, Replication, and the Hardest Science

Cesario, J. (2014) · Perspectives on Psychological Science · doi:10.1177/1745691613513470 · Cited by 320 · see citing works

Adhesion events in angiogenesis

Eliceiri, B. P., & Cheresh, D. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00252-0 · Cited by 287 · see citing works

A comprehensive review of retinal gene therapy

Boye, S. E., Boye, S. L., Lewin, A. S., & Hauswirth, W. W. (2013) · Molecular Therapy · doi:10.1038/mt.2012.280 · Cited by 262 · see citing works

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Morris, S. B., Xue, Y. Y., Burdick, M. D., Glass, M. C., Iannettoni, M. D., & Strieter, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3145 · Cited by 259 · see citing works

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration

Yu, Y., Bhangale, T. R., Fagerness, J., Ripke, S., Thorleifsson, G., Tan, P. L., Souied, E. H., Richardson, A. J., Merriam, J. E., Buitendijk, G. H. S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr270 · Cited by 254 · see citing works

Proinflammatory functions of vascular endothelial growth factor in alloimmunity

Reinders, M. E. J., Sho, M., Izawa, A., Wang, P., Mukhopadhyay, D., Koss, K. E., Geehan, C. S., Luster, A. D., Sayegh, M. H., & Briscoe, D. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17712 · Cited by 251 · see citing works

Matricryptins and matrikines: biologically active fragments of the extracellular matrix

Ricard‐Blum, S., & Salza, R. (2014) · Experimental Dermatology · doi:10.1111/exd.12435 · Cited by 224 · see citing works

An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential

Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., & Helman, L. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006767007547 · Cited by 207 · see citing works

Extracellular matrix scaffolding in angiogenesis and capillary homeostasis

Marchand, M., Monnot, C., Muller, L., & Germain, S. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.08.007 · Cited by 205 · see citing works

Endogenous inhibitors of angiogenesis

Ribatti, D. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.019 · Cited by 191 · see citing works

Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study

Campochiaro, P. A., Lauer, A. K., Sohn, E. H., Mir, T. A., Naylor, S., Anderton, M. C., Kelleher, M., Harrop, R., Ellis, S., & Mitrophanous, K. A. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.117 · Cited by 186 · see citing works

Recruitment of Progenitor Cells by an Extracellular Matrix Cryptic Peptide in a Mouse Model of Digit Amputation

Agrawal, V., Tottey, S., Johnson, S. A., Freund, J. M., Siu, B. F., & Badylak, S. F. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0036 · Cited by 180 · see citing works

Bacteria as vectors for gene therapy of cancer

Baban, C. K., Cronin, M., O’Hanlon, D., O’Sullivan, G. C., & Tangney, M. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.6.13146 · Cited by 175 · see citing works

Angiongenesis: a new theory for endometriosis

Healy, D. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.736 · Cited by 173 · see citing works

Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2

Keskin, D., Kim, J., Cooke, V. G., Wu, C.-C., Sugimoto, H., Gu, C., De Palma, M., Kalluri, R., & LeBleu, V. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.035 · Cited by 165 · see citing works

The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds

Agren, M. S., & Werthen, M. (2007) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734607301394 · Cited by 136 · see citing works

Endostatin gene therapy delivered by <i>Salmonella choleraesuis</i> in murine tumor models

Lee, C., Wu, C., & Shiau, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.626 · Cited by 93 · see citing works

Microvascular complications and diabetic retinopathy: recent advances and future implications

Barot, M., Gokulgandhi, M. R., Patel, S., & Mitra, A. K. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.206 · Cited by 92 · see citing works

Addressing tumor blood vessels

Folkman, J. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-510 · Cited by 89 · see citing works

Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update

Lin, F.-L., Wang, P.-Y., Chuang, Y.-F., Wang, J.-H., Wong, V. H. Y., Bui, B. V., & Liu, G.-S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.029 · Cited by 74 · see citing works

Matrikines for therapeutic and biomedical applications

Sivaraman, K., & Shanthi, C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.056 · Cited by 50 · see citing works

Involvement of RB gene family in tumor angiogenesis

Gabellini, C., Del Bufalo, D., & Zupi, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209631 · Cited by 47 · see citing works

Toward improved <i>in vitro</i> models of human cancer

Ayuso, J. M., Park, K.-Y., Virumbrales-Muñoz, M., & Beebe, D. J. (2021) · APL Bioengineering · doi:10.1063/5.0026857 · Cited by 40 · see citing works

Bruch’s Membrane and the Choroid in Age-Related Macular Degeneration

Edwards, M., & Lutty, G. A. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-66014-7_4 · Cited by 32 · see citing works

A personal voyage through the proteoglycan field

Lindahl, U. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.001 · Cited by 28 · see citing works

Parathyroid Hormone Remodels Bone Transitional Vessels and the Leptin Receptor-Positive Pericyte Network in Mice

Caire, R., Roche, B., Picot, T., Aanei, C.-M., He, Z., Campos, L., Thomas, M., Malaval, L., Vico, L., & Lafage-Proust, M.-H. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3728 · Cited by 27 · see citing works

The history of angiogenesis inhibitors

Ribatti, D. (2007) · Leukemia · doi:10.1038/sj.leu.2404756 · Cited by 15 · see citing works

Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives

Jacobsen, A., Siebler, J., Grützmann, R., Stürzl, M., & Naschberger, E. (2024) · Cancers · doi:10.3390/cancers16050890 · Cited by 11 · see citing works

Tumor Neoangiogenesis Inhibitors——Angiostatin and Endostatin Implication

Wu, Y. (2003) · Journal of Chongqing University. English Edition

Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

Yokoyama, Y., Dhanabal, M., Griffioen, A. W., Sukhatme, V. P., & Ramakrishnan, S. (2000) · PubMed · Cited by 228 · see citing works

2D numerical simulation of effect of antiangiogenic factors Angiostatin and Endostatin on tumor-induced angiogenesis

Shi-xiong, X. (2006) · Journal of Medical Biomechanics · Cited by 3 · see citing works

Numerical simulation of solid tumor angiogenesis with Endostatin treatment: a combined analysis of inhibiting effect of anti-angiogenic factor and micro mechanical environment of extracellular matrix

Cai, Y., Wu, J., Gulnar, K., et al. (2009) · Applied Mathematics and Mechanics · doi:10.1007/s10483-009-1004-z · Cited by 6 · see citing works

The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cells

Hajitou, A., Grignet, C., Devy, L., Berndt, S., Blacher, S., Deroanne, C., Bajou, K., Fong, T. A. T., Chiang, Y., Foidart, J., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0109fje · Cited by 165 · see citing works